Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Context: In adults, craniopharyngioma (CP) of either childhood-onset (CO-CP) or adult-onset (AO-CP) is associated with increased morbidity and mortality, but data on the relative risks (RRs) of contributing factors are lacking. Objective: To assess the RRs of factors contributing to morbidity and mortality in adults with CO-CP and AO-CP. Methods: Data on 1669 patients with CP from KIMS (Pfizer International Metabolic Database) were analyzed using univariate and multiple Poisson and Cox regression methods. Results: When CO-CP and AO-CP groups were combined, history of stroke and hyperlipidemia increased cardiovascular risk, higher body mass index (BMI) and radiotherapy increased cerebrovascular risk, and increased waist circumference increased the risk of developing diabetes mellitus (DM). Compared with patients with CO-CP, patients with AO-CP had a threefold higher risk of tumor recurrence, whereas being female and previous radiotherapy exposure conferred lower risks. Radiotherapy and older age with every 10 years from disease onset conferred a 2.3- to 3.5-fold risk for developing new intracranial tumors, whereas older age, greater and/or increasing BMI, history of stroke, and lower insulinlike growth factor I (IGF-I) standard deviation score measured at last sampling before death were related to increased all-cause mortality. Compared with the general population, adults with CP had 9.3-, 8.1-, and 2.2-fold risks of developing DM, new intracranial tumors, and early death, respectively. Conclusion: Conventional factors that increase the risks of cardio- and cerebrovascular diseases and DM and risks for developing new intracranial tumors contributed to excess morbidity and mortality. In addition, lower serum IGF-I level measured from the last sample before death was inversely associated with mortality risk in patients with CP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047 · cited 1×
“All patients included in the current study had confirmed diagnosis of severe GHD by GH stimulation testing or had at least three pituitary hormone deficiencies and a low serum insulinlike growth factor I (IGF-I) standard deviation score (SDS),22, in accordance with current clinical practice guidelines (18, 19).”
MethodIncidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden
Thunander, M., Petersson, C., Jonzon, K., Fornander, J., Ossiansson, B., Torn, C., Edvardsson, S., & Landin-Olsson, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.07.022 · Cited by 218
Burman, P., Mattsson, A. F., Johannsson, G., Höybye, C., Holmer, H., Dahlqvist, P., Berinder, K., Engström, B. E., Ekman, B., Erfurth, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4059 · Cited by 184 · cited 2×
“mortality rates were comparable to those of the reference population (13).”
BackgroundResultSelf-citationExcess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies
Pappachan, J. M., Raskauskiene, D., Kutty, V. R., & Clayton, R. N. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3787 · Cited by 138 · cited 1×
“(17), reported beneficial effects favoring GH re-”
Morbidity and mortality in patients with craniopharyngioma after surgery
Crowley, R. K., Hamnvik, O. P., O’Sullivan, E. P., Behan, L. A., Smith, D., Agha, A., & Thompson, C. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03838.x · Cited by 108 · cited 1×
“which cannot be attributed solely to endocrine abnormalities (7).”
BackgroundVerhelst, J., Mattsson, A. F., Luger, A., Thunander, M., Góth, M. I., Kołtowska-Häggström, M., & Abs, R. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0599 · Cited by 71 · cited 1×
“Serum IGF-I and lipid levels were measured centrally, as described previously (23), and plasma glucose and hemoglobin A1c levels were analyzed locally at each participating center.”
MethodSelf-citation
Cited by
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Self-citationGrowth hormone replacement therapy in childhood-onset craniopharyngioma
van Iersel, L., van Schaik, J., & van Santen, H. M. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.101998 · Cited by 6
Mortality in craniopharyngiomas: data from the last two decades
Ntali, G., Shafi, A. M., & Karavitaki, N. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102049 · Cited by 1
Metadata
- Authors
- Yuen, K. C. J., Mattsson, A. F., Burman, P., Erfurth, E.-M., Camacho-Hubner, C., Fox, J. L., Verhelst, J., Geffner, M. E., & Abs, R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-09-29
- Volume
- 103
- Issue
- 2
- Pages
- 768-777
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2758365017
- Cited by
- 33
- References
- 6
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement. https://app.cochat.ai/papers/10.1210/jc.2017-01542
- The paper
- Yuen, K. C. J., Mattsson, A. F., Burman, P., Erfurth, E.-M., Camacho-Hubner, C., Fox, J. L., Verhelst, J., Geffner, M. E., & Abs, R. (2018). Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2017-01542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.